At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:19 ET
Fidelity (FMR LLC) filed an amended Schedule 13G reporting beneficial ownership of 66,743,389.66 shares of Lexicon Pharmaceuticals common stock as of September 30, 2026, representing 15.0% of shares outstanding. This is an increase from the prior filing (August 2026) which reported 66,739,266 shares at 15.0%, indicating a modest net addition of about 4,124 shares. The filing is routine for a passive institutional holder and coincides with Lexicon's Q3 2026 earnings release showing declining revenue and a wider net loss.
- FMR LLC reported beneficial ownership of 66,743,389.66 shares of Lexicon Pharmaceuticals common stock as of September 30, 2026
- The stake represents 15.0% of shares outstanding
- This is an amendment to a Schedule 13G, indicating passive investment intent
- The filing date is November 5, 2026, the same day as Lexicon's Q3 2026 earnings release
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access